TAK

#7026
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
18.7400
+1.22%
版块:
基础:
利润货币:
日范围
18.7100
18.7600
年范围
12.9900
18.8200
日变化
+1.22%
每月变动
+12.62%
6个月变化
+32.11%
年变化
+32.11%
前一天收盘价
18.5150
Open
18.7250
Bid
Ask
Low
18.7100
High
18.7600
交易量
504
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24 TTM

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

新闻